Skip to Main

Search

Results 121 to 130 of 1,044 for ""

HHSC, UT Southwestern plan for New State Psychiatric Hospital in Dallas-Fort Worth Metroplex: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2021/new-state-psychiatric-hospital.html

The Texas Health and Human Services Commission and the University of Texas Southwestern Medical Center are developing plans for a new state psychiatric hospital in the Dallas-Fort Worth area, with $44.7 million in state funding approved this Legislative session.

Surgical masks as good as respirators for flu and respiratory virus protection: Newsroom - UT Southwestern, Dallas, TX

https://www.utsouthwestern.edu/newsroom/articles/year-2019/surgical-masks-virus-protection.html

The study reported “no significant difference in the effectiveness” of medical masks vs. N95 respirators for prevention of influenza or other viral respiratory illness.

NIH awards UT Southwestern researchers $4.4 million to study the genetic basis of vocal learning: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2021/roberts-takahashi-nih-awards.html

A UT Southwestern research team has received the National Institutes of Health’s prestigious Transformative Research Award to further their study of zebra finches to investigate the genetic basis of vocal imitation abilities.

Scientists discover “jumping” genes that can protect against blood cancers : Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2021/scientists-discover-jumping-genes.html

New research has uncovered a surprising role for so-called “jumping” genes that have traditionally been considered a source of genetic mutations responsible for a number of human diseases.

UT Southwestern finds crucial new molecular mechanisms and biomarkers in ovarian cancer: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2021/new-molecular-mechanisms-and-biomarkers.html

UT Southwestern faculty have discovered what appears to be an Achilles’ heel in ovarian cancers, as well as new biomarkers that could point to which patients are the best candidates for possible new treatments.

Racial disparities in heart failure explained: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2020/racial-disparities-heart-failure.html

Researchers at UT Southwestern have uncovered evidence that the higher prevalence of “malignant” enlargement of the heart among blacks contributes to the higher incidence of heart failure in this population.

Casting call: Why immobilizing helps in healing: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2020/why-immobilizing-helps-in-healing.html

Immobilization is the most common treatment, and yet, until recently, it was unknown exactly why this technique worked to advance healing.

Simmons Cancer Center joins elite network - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2020/simmons-cancer-center-joins-elite-network-of-institutions.html

The March 21 decision by NCCN to include the Simmons Cancer Center among its members recognizes Simmons Cancer Center’s elite status and will deepen its collaboration with national peers at the highest levels.

Advanced MRI scans may improve treatment of tremor, Parkinson's disease: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2020/advanced-mri-scans-may-improve-treatment-of-tremor-parkinsons-disease.html

Recently developed MRI techniques used to more precisely target a small area in the brain linked to Parkinson’s disease.

Researchers find evidence a cancer drug may be extended to many more patients: Newsroom - UT Southwestern, Dallas, TX

https://www.utsouthwestern.edu/newsroom/articles/year-2019/cancer-drug-extended-to-more-patients.html

Drugs currently used to treat less than 10 percent of breast cancer patients could have broader effectiveness in treating ovarian and prostate cancers.